title: Metabolic and respiratory effects of infused sodium acetate in healthy human subjects.
abstract: The metabolic and respiratory effects of intravenous 0.5 M sodium acetate (at a rate of 2.5 mmol/min during 120 min) were studied in nine normal human subjects. O2 consumption (VO2) and CO2 production (VCO2) were measured continuously by open-circuit indirect calorimetry. VO2 increased from 251 +/- 9 to 281 +/- 9 ml/min (P < 0.001), energy expenditure increased from 4.95 +/- 0.17 kJ/min baseline to 5.58 +/- 0.16 kJ/min (P < 0.001), and VCO2 decreased nonsignificantly (211 +/- 7 ml/min vs. 202 +/- 7 ml/min, NS). The extrapulmonary CO2 loss (i.e., bicarbonate generation and excretion) was estimated at 48 +/- 5 ml/min. This observation is consistent with 1 mol of bicarbonate generated from 1 mol of acetate metabolized. Alveolar ventilation decreased from 3.5 +/- 0.2 l/min basal to 3.1 +/- 0.2 l/min (P < 0.001). The minute ventilation (VE) to VO2 ratio decreased from 22.9 +/- 1.3 to 17.6 +/- 0.9 l/l (P < 0.005), arterial PO2 decreased from 93.2 +/- 1.9 to 78.7 +/- 1.6 mmHg (P < 0.0001), arterial PCO2 increased from 39.2 +/- 0.7 to 42.1 +/- 1.1 mmHg (P < 0.0001), pH from 7.40 +/- 0.005 to 7.50 +/- 0.007 (P < 0.005), and arterial bicarbonate concentration from 24.2 +/- 0.7 to 32.9 +/- 1.1 (P < 0.0001). These observations indicate that sodium acetate infusion results in substantial extrapulmonary CO2 loss, which leads to a relative decrease of total and alveolar ventilation.
authors: Department of Anesthesiology, Lausanne University Hospital, Switzerland.
authors: P
authors: P
authors: Burnier
authors: L
authors: L
authors: Tappy
authors: E
authors: E
authors: Jéquier
authors: D
authors: D
authors: Schneeberger
authors: R
authors: R
authors: Chioléro
mesh_terms: D000085:Acetates / Q000494:pharmacology*; D019342:Acetic Acid; D000328:Adult; D001639:Bicarbonates / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008660:Metabolism / Q000187:drug effects*; D010084:Oxidation-Reduction / Q000187:drug effects; D011659:Pulmonary Gas Exchange / Q000187:drug effects; D012016:Reference Values; D012119:Respiration / Q000187:drug effects*
chemical_list: D000085:Acetates; D001639:Bicarbonates; D005230:Fatty Acids, Nonesterified; D019342:Acetic Acid